Literature DB >> 14500302

How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?

E D G McIntosh1.   

Abstract

BACKGROUND: It is likely that disease specific infectious morbidity is under-reported. Microbiologically identifiable diseases may be "hidden" in ICD-10 code as "unspecified" disease. AIMS: To estimate the proportion of "unspecified" morbidity of infectious cause in infants and young children reported by Hospital Episode Statistics (HES) in England in 1999 that could reasonably be attributed to Streptococcus pneumoniae, and to calculate what number and proportion of diseases could potentially be prevented by a programme of pneumococcal conjugate vaccination.
METHODS: Proportions of HES "unspecified" septicaemia, meningitis, and pneumonia attributable to pneumococcal infection were estimated by applying theoretical rates obtained from studies using highly sensitive diagnostic tests. The numbers obtained were added to those coded as pneumococcal in origin. The vaccine preventable proportion was then calculated using serogroup coverage, disease specific efficacy, and vaccine uptake.
RESULTS: For infants and children 3 months to 5 years of age in 1999, HES reported 134, 245, and 216 episodes of pneumococcal septicaemia, meningitis, and pneumonia respectively. In addition, 68, 36, and 2548 episodes of "unspecified" disease respectively are probably pneumococcal in origin. For hospitalisations in England in this age group, 157/202 (78%) cases of pneumococcal septicaemia, 218/281 (76%) cases of pneumococcal meningitis, and 452/2764 (16%) cases of pneumococcal pneumonia may be preventable annually by means of pneumococcal conjugate vaccination.
CONCLUSIONS: Paediatric hospital morbidity in England due to pneumococcal septicaemia, meningitis, and pneumonia is under-reported by 34%, 13% and 92% respectively. A larger proportion of morbidity is preventable than implied by ICD-10 code alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500302      PMCID: PMC1719322          DOI: 10.1136/adc.88.10.859

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa.

Authors:  J A Berkley; I Mwangi; C J Ngetsa; S Mwarumba; B S Lowe; K Marsh; C R Newton
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

2.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Authors:  S Black; H Shinefield; B Fireman; E Lewis; P Ray; J R Hansen; L Elvin; K M Ensor; J Hackell; G Siber; F Malinoski; D Madore; I Chang; R Kohberger; W Watson; R Austrian; K Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

3.  Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

Authors:  E Miller; P Waight; A Efstratiou; M Brisson; A Johnson; R George
Journal:  Acta Paediatr Suppl       Date:  2000-12

4.  Recurrent pneumococcal bacteremia: risk factors and outcomes.

Authors:  G S Turett; S Blum; E E Telzak
Journal:  Arch Intern Med       Date:  2001-09-24

5.  Invasive pneumococcal disease in England and Wales: vaccination implications.

Authors:  K Sleeman; K Knox; R George; E Miller; P Waight; D Griffiths; A Efstratiou; K Broughton; R T Mayon-White; E R Moxon; D W Crook
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

6.  Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?

Authors:  E D G McIntosh; R Booy
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

7.  Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children.

Authors:  P Toikka; S Nikkari; O Ruuskanen; M Leinonen; J Mertsola
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Detection of Streptococcus pneumoniae in whole blood by PCR.

Authors:  Y Zhang; D J Isaacman; R M Wadowsky; J Rydquist-White; J C Post; G D Ehrlich
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors:  Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129

Review 10.  Should the new pneumococcal vaccine be used in high-risk children?

Authors:  A Finn; R Booy; R Moxon; M Sharland; P Heath
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

View more
  2 in total

1.  Prevalence of Heptavalent Vaccine-related Pneumococcal Serotypes in Nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during 2010- 2011.

Authors:  Abolfazl Khoshdel; Reza Imani Rastabi; Abbas Doosti; Shahin Askari; Masoud Hafizi
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.

Authors:  Stuart C Clarke; Johanna M Jefferies; Andrew J Smith; Jim McMenamin; Timothy J Mitchell; Giles F S Edwards
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.